Risk of cardiovascular diseases and stroke events in methamphetamine users: A 10-year follow-up study

Journal of Clinical Psychiatry

Volumn 77, Issue 10, 2016, Pages 1396-1403

  Huang, Ming Chyi ^a,b   Yang, Shu Yu ^a   Lin, Shih Ku ^b   Chen, Kuan Yu ^a,d   Chen, Ying Yeh ^a,d   Kuo, Chian Jue ^a,b   Hung, Yen Ni ^c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b University School of Medicine   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART ARRHYTHMIA; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; PRIORITY JOURNAL; TAIWANESE; AGED; AMPHETAMINE-RELATED DISORDERS; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COMPLICATION; CROSS-SECTIONAL STUDY; FOLLOW UP; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK; STROKE; TAIWAN; YOUNG ADULT;

CENTRAL STIMULANT AGENT; METHAMPHETAMINE;

ADULT; AGED; AMPHETAMINE-RELATED DISORDERS; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM STIMULANTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; METHAMPHETAMINE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; STROKE; TAIWAN; YOUNG ADULT;

EID: 84992745456     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m09872     Document Type: Article

References (45)

1. Darke S, Kaye S, McKetin R, et al. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253-262. doi:10.1080/09595230801923702 PubMed
2. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci. 1999;44(2):359-368. doi:10.1520/JFS1464J PubMed
3. Kaye S, Darke S, Duflou J, et al. Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction. 2008;103(8):1353-1360. doi:10.1/j.1360-043.208.0231.x PubMed
4. Kaye S, McKetin R, Duflou J, et al. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction. 2007;102(8):1204-1211. doi:10.1/j.1360-043.207.01874.x PubMed
5. Yeo KK, Wijetunga M, Ito H, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med. 2007;120(2):165-171. doi:10.1016/j.amjmed.206.01.024 PubMed
6. Ho EL, Josephson SA, Lee HS, et al. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care. 2009;10(3):295-305. doi:10.107/s12028-08-917-5 PubMed
7. Yeung M, Bhalla A, Birns J. Recreational drug misuse and stroke. Curr Drug Abuse Rev. 2011;4(4):286-291. doi:10.2174/1874737104040286 PubMed
8. de los Ríos F, Kleindorfer DO, Khoury J, et al. Trends in substance abuse preceding stroke among young adults: a population-based study. Stroke. 2012;43(12):3179-3183. doi:10.161/STROKEAHA.12.67808 PubMed
9. Ito H, Yeo KK, Wijetunga M, et al. A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse. Clin Cardiol. 2009;32(6):E18-E22. doi:10.102/clc.20367 PubMed
10. Turnipseed SD, Richards JR, Kirk JD, et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med. 2003;24(4):369-373. doi:10.1016/S0736-4679(03)031-3 PubMed
11. Waksman J, Taylor RN Jr., Bodor GS, et al. Acute myocardial infarction associated with amphetamine use. Mayo Clin Proc. 2001;76(3):323-326. doi:10.4065/76.3.323 PubMed
12. Wijetunga M, Bhan R, Lindsay J, et al. Acute coronary syndrome and crystal methamphetamine use: a case series. Hawaii Med J. 2004;63(1):8-13, PubMed
13. Wijetunga M, Seto T, Lindsay J, et al. Crystal methamphetamine-Associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol. 2003;41(7):981-986. doi:10.1081/CLT-12026521 PubMed
14. Yu Q, Larson DF, Watson RR. Heart disease, methamphetamine, and AIDS. Life Sci. 2003;73(2):129-140. doi:10.1016/S024-3205(03)0260-1 PubMed
15. Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64(4):495-502. doi:10.101/archpsyc.64.4.495 PubMed
16. Gau SS, Chung CH, Gau CS. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in Taiwan. J Clin Psychopharmacol. 2008;28(3):271-278. doi:10.1097/JCP.0b013e3181723713 PubMed
17. Chen WJ, Fu TC, Ting TT, et al. Use of ecstasy and other psychoactive substances among school-Attending adolescents in Taiwan: national surveys 2004-2006. BMC Public Health. 2009;9(1):27. doi:10.186/1471-2458-9-27 PubMed
18. Chiang SC, Chen CY, Chang YY, et al. Prevalence of heroin and methamphetamine male users in the northern Taiwan, 1999-2002: capturerecapture estimates. BMC Public Health. 2007;7(1):292. doi:10.186/1471-2458-7-292 PubMed
19. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;79:516-524.
20. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. doi:10.1097/01.mlr.0182534.19832.83 PubMed
21. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075-1079, discussion 1081-1090. doi:10.1016/0895-4356(93)90103-8 PubMed
22. Kuo CJ, Yang SY, Liao YT, et al. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull. 2013;39(3):648-657. doi:10.1093/schbul/sbr202 PubMed
23. Quail JM, Lix LM, Osman BA, et al. Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts. BMC Health Serv Res. 2011;11(1):146. doi:10.186/1472-6963-1-146 PubMed
24. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265-2281. doi:10.102/(SICI)1097-0258(1981015)17:193.0.CO;2-B PubMed
25. Shah BR, Laupacis A, Hux JE, et al. Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol. 2005;58(6):550-559. doi:10.1016/j.jclinepi.204.10.016 PubMed
26. Lin HC, Tsai SY, Lee HC. Increased risk of developing stroke among patients with bipolar disorder after an acute mood episode: a sixyear follow-up study. J Affect Disord. 2007;100(1-3):49-54. doi:10.1016/j.jad.206.09.016 PubMed
27. Lin HC, Tsai SY, Lee HC. No higher risk of myocardial infarction among bipolar patients in a 6-year follow-up of acute mood episodes. Psychosom Med. 2008;70(1):73-76. doi:10.1097/PSY.0b013e31815c1e93 PubMed
28. Maeno Y, Iwasa M, Inoue H, et al. Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes. Int J Legal Med. 2000;113(4):201-207. doi:10.107/s0414908 PubMed
29. Inouye DS, Navin JJ, Hardman JM. Fatal postoperative arrhythmia in a man with a remote history of methamphetamine and cocaine use: a case report. Hawaii Med J. 2004;63(3):82-86. PubMed
30. Varner KJ, Ogden BA, Delcarpio J, et al. Cardiovascular responses elicited by the "binge" administration of methamphetamine. J Pharmacol Exp Ther. 2002;301(1):152-159. doi:10.124/jpet.301.1.152 PubMed
31. Yoshida K, Morimoto A, Makisumi T, et al. Cardiovascular, thermal and behavioral sensitization to methamphetamine in freely moving rats. J Pharmacol Exp Ther. 1993;267(3):1538-1543. PubMed
32. Fukunaga T, Mizoi Y, Adachi J. Methamphetamine-induced changes of peripheral catecholamines: an animal experiment to elucidate the cause of sudden death after methamphetamine abuse. Nippon Hoigaku Zasshi. 1987;41(4):335-341. PubMed
33. Haning W, Goebert D. Electrocardiographic abnormalities in methamphetamine abusers. Addiction. 2007;102(suppl 1):70-75. doi:10.1/j.1360-043.206.0176.x PubMed
34. Henry BL, Minassian A, Perry W. Effect of methamphetamine dependence on heart rate variability. Addict Biol. 2012;17(3):648-658. doi:10.1/j.1369-160.2010.0270.x PubMed
35. Pasic J, Russo JE, Ries RK, et al. Methamphetamine users in the psychiatric emergency services: a case-control study. Am J Drug Alcohol Abuse. 2007;33(5):675-686. doi:10.1080/09529070152732 PubMed
36. Richards JR, Bretz SW, Johnson EB, et al. Methamphetamine abuse and emergency department utilization. West J Med. 1999;170(4):198-202. PubMed
37. Maulik N, Wei Z, Liu X, et al. Improved postischemic ventricular functional recovery by amphetamine is linked with its ability to induce heat shock. Mol Cell Biochem. 1994;137(1):17-24. doi:10.107/BF0926035 PubMed
38. Petitti DB, Sidney S, Quesenberry C, et al. Stroke and cocaine or amphetamine use. Epidemiology. 1998;9(6):596-600. doi:10.1097/01648-19810-05 PubMed
39. Ohta K, Mori M, Yoritaka A, et al. Delayed ischemic stroke associated with methamphetamine use. J Emerg Med. 2005;28(2):165-167. doi:10.1016/j.jemermed.204.06.015 PubMed
40. Anker JJ, Baron TR, Zlebnik NE, et al. Escalation of methamphetamine self-Administration in adolescent and adult rats. Drug Alcohol Depend. 2012;124(1-2):149-153. doi:10.1016/j.drugalcdep.2012.01.04 PubMed
41. Baumeister SE, Tossmann P. Association between early onset of cigarette, . alcohol and cannabis use and later drug use patterns: an analysis of a survey in European metropolises. Eur Addict Res. 2005;11(2):92-98. doi:10.159/083038 PubMed
42. Kokoshka JM, Fleckenstein AE, Wilkins DG, et al. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J Neurochem. 2000;75(5):2095-2102. doi:10.1046/j.1471-4159.20.0752095.x PubMed
43. Falck RS, Wang J, Carlson RG, et al. Perceived need for substance abuse treatment among illicit stimulant drug users in rural areas of Ohio, Arkansas, and Kentucky. Drug Alcohol Depend. 2007;91(2-3):107-114. doi:10.1016/j.drugalcdep.207.05.015 PubMed
44. Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236-242. doi:10.102/pds.2087 PubMed
45. Wu CS, Wang SC, Gau SS, et al. Association of stroke with the receptorbinding profiles of antipsychotics-A case-crossover study. Biol Psychiatry. 2013;73(5):414-421. doi:10.1016/j.biopsych.2012.07.06 PubMed